GL1X · GenesisL1 explorer

Research workbench

Crystal structure of fabi from S. aureus in complex with a novel benzimidazole inhibitor

Analyse Crystal structure of fabi from S. aureus in complex with a novel benzimidazole… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4NZ9
Type
protein
Length
509 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enoyl-[acyl-carrier-protein] reductase [NADPH]
EC
1.3.1.39
UniProt
Q2FI66
Ligands
1JT, NAP
Pockets
5 · best druggability 0.82

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEnoyl-[acyl-carrier-protein] reductase [NADPH] (EC 1.3.1.39)protein25549% helix, 15% strandQ2FI66
BEnoyl-[acyl-carrier-protein] reductase [NADPH] (EC 1.3.1.39)protein25449% helix, 15% strandQ2FI66

Ligands and binding sites

  • 1JT · 1-(4-methoxy-3-methylbenzyl)-5,6,7,8-tetrahydro-1H-naphtho[2,3-d]imidazole · ligand · 2 copies · chains A, B
  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17150.820.85601JT, NAP
27710.810.84661JT, NAP
32730.570.7736empty
42200.510.7627empty
5750.400.7918empty

Interfaces

1 interface between chains.

  • A–B · 1390 Ų buried · 20 hydrogen bonds · protein-protein

Compared structures

  • 4NZ9 · Crystal Structure of FabI from S. aureus in complex with a novel benzimidazole inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.